Obesity is a documented side effect of long-term GCs exposure, and GCs exert their physiological and pharmacological effect by binding to the nuclear receptor-glucocorticoid receptor (GR). This evidence concerns the gene NR3C1 and obesity due to melanocortin 4 receptor deficiency.